iLIVER2025，Vol.4Issue(3)：P.125-134,10.DOI:10.1016/j.iliver.2025.100178
Nucleic acid therapeutics for liver diseases:A decade of technological convergence and clinical challenges
Yufei Pan 1Mingyue Pan 2Yuanzheng Huang 3Baoping Lian 4Yutian Feng 5Juan Liu 5Xiaoxuan Liu1
作者信息
- 1. State Key Laboratory of Natural Medicines,Joint International Research Laboratory of Target Discovery and New Drug Innovation(Ministry of Education),Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 210009,Jiangsu,China
- 2. State Key Laboratory of Natural Medicines,Joint International Research Laboratory of Target Discovery and New Drug Innovation(Ministry of Education),Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 210009,Jiangsu,China Hepato-Pancreato-Biliary Center,Beijing Tsinghua Changgung Hospital,Key Laboratory of Digital Intelligence Hepatology(Ministry of Education),School of Clinical Medicine,Tsinghua Medicine,Tsinghua University,Beijing 102218,China
- 3. State Key Laboratory of Natural Medicines,Joint International Research Laboratory of Target Discovery and New Drug Innovation(Ministry of Education),Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 210009,Jiangsu,China State Key Laboratory of Natural Medicines,Joint International Research Laboratory of Target Discovery and New Drug Innovation(Ministry of Education),Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 210009,Jiangsu,China
- 4. State Key Laboratory of Natural Medicines,Joint International Research Laboratory of Target Discovery and New Drug Innovation(Ministry of Education),Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 210009,Jiangsu,China Aix-Marseille Universite,CNRS,Centre Interdisciplinaire de Nanoscience de Marseille,UMR 7325,Equipe Labellisee Ligue Contre le Cancer,Marseille 13288,France
- 5. Hepato-Pancreato-Biliary Center,Beijing Tsinghua Changgung Hospital,Key Laboratory of Digital Intelligence Hepatology(Ministry of Education),School of Clinical Medicine,Tsinghua Medicine,Tsinghua University,Beijing 102218,China
- 折叠
摘要
关键词
Nucleic acid therapeutics/Liver diseases/Bibliometric analysis分类
医药卫生引用本文复制引用
Yufei Pan,Mingyue Pan,Yuanzheng Huang,Baoping Lian,Yutian Feng,Juan Liu,Xiaoxuan Liu..Nucleic acid therapeutics for liver diseases:A decade of technological convergence and clinical challenges[J].iLIVER,2025,4(3):P.125-134,10.基金项目
supported by National Key Research&Development Program of China for International S&T Cooperation Projects(2018YFE0117800) （2018YFE0117800）
the Project Program of State Key Laboratory of Natural Medicines(China Pharmaceutical University,No.SKLNMZZ2024JS18) （China Pharmaceutical University,No.SKLNMZZ2024JS18）
National Natural-Science Foundation of China(No.32371477 and No.82090051). （No.32371477 and No.82090051）
